Tags: Multiple myeloma,plasma cell cancer,bone marrow cancer,M protein,CRAB symptoms,monoclonal gammopathy,stem cell transplant,immunomodulatory drugs,proteasome inhibitors,skeletal survey,serum free light chain assay,bone lesions,hypercalcemia,renal insufficiency,anemiaursodiol therapy,UDCA treatment,PBC medication options,Ocaliva (obeticholic acid),second-line PBC treatments,cholestatic liver disease management,antimitochondrial antibody treatment,liver transplantation PBC,PBC symptom management,autoimmune liver disease therapyPneumococcal vaccine,pneumonia prevention,streptococcus pneumoniae,PCV13,PPSV23,adult vaccination,childhood immunization,invasive pneumococcal disease,herd immunity,vaccine schedule,pneumococcal conjugate vaccine,pneumococcal polysaccharide vaccine,high-risk groups,side effects,vaccine effectiveness,pneumococcal meningitis,bacterial pneumonia,CDC recommendations,booster shots,pneumococcal serotypessafetyhazards